Peritoneal Metastases in Colorectal Cancer: Biology and Barriers

go back to reference Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nature Communications 2018; 9(1). https://doi.org/10.1038/s41467-018-04278-6. Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nature Communications 2018; 9(1). https://​doi.​org/​10.​1038/​s41467-018-04278-6.

go back to reference Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. Journal of Clinical Oncology 2007; 25(29):4575–4580. https://doi.org/10.1200/JCO.2007.11.0833.CrossRefPubMed Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. Journal of Clinical Oncology 2007; 25(29):4575–4580. https://​doi.​org/​10.​1200/​JCO.​2007.​11.​0833.CrossRefPubMed

go back to reference Pfannschmidt J, Dienemann H, Hoffmann H. Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published Series. Annals of Thoracic Surgery 2007; 84(1):324–338.CrossRefPubMed Pfannschmidt J, Dienemann H, Hoffmann H. Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published Series. Annals of Thoracic Surgery 2007; 84(1):324–338.CrossRefPubMed

go back to reference Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FAN. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology 2003; 21(20):3737–3743. https://doi.org/10.1200/JCO.2003.04.187.CrossRefPubMed Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FAN. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology 2003; 21(20):3737–3743. https://​doi.​org/​10.​1200/​JCO.​2003.​04.​187.CrossRefPubMed

go back to reference Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Annals of Surgical Oncology 2008; 15(9):2426–2432. https://doi.org/10.1245/s10434-008-9966-2.CrossRefPubMed Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Annals of Surgical Oncology 2008; 15(9):2426–2432. https://​doi.​org/​10.​1245/​s10434-008-9966-2.CrossRefPubMed

go back to reference Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, De Forges H, Stanbury T, Paineau J, Glehen O. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. Journal of Clinical Oncology 2018; 36(18_suppl):LBA3503–LBA3503. https://doi.org/10.1200/jco.2018.36.18_suppl.lba3503.CrossRef Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, De Forges H, Stanbury T, Paineau J, Glehen O. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. Journal of Clinical Oncology 2018; 36(18_suppl):LBA3503–LBA3503. https://​doi.​org/​10.​1200/​jco.​2018.​36.​18_​suppl.​lba3503.CrossRef

go back to reference Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331(6024):1559–1564.CrossRefPubMed Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331(6024):1559–1564.CrossRefPubMed

go back to reference Jacobson R, Sherman SK, Dadaleh F, Turaga KK. Peritoneal Metastases in Colorectal Cancer. Annals of surgical oncology 2018; 25(8):2145–2151. https://doi.org/10.1245/s10434-018-6490-x.CrossRefPubMed Jacobson R, Sherman SK, Dadaleh F, Turaga KK. Peritoneal Metastases in Colorectal Cancer. Annals of surgical oncology 2018; 25(8):2145–2151. https://​doi.​org/​10.​1245/​s10434-018-6490-x.CrossRefPubMed

go back to reference Hellman S, Weichselbaum RR. Oligometastases. Journal of Clinical Oncology 1995; 13(1):8–10. https://doi.org/10.1200/JCO.1995.13.1.8.CrossRefPubMed Hellman S, Weichselbaum RR. Oligometastases. Journal of Clinical Oncology 1995; 13(1):8–10. https://​doi.​org/​10.​1200/​JCO.​1995.​13.​1.​8.CrossRefPubMed

go back to reference Weichselbaum RR, Hellman S. Oligometastases revisited. Nature Reviews Clinical Oncology 2011; 8(6):378–382.CrossRefPubMed Weichselbaum RR, Hellman S. Oligometastases revisited. Nature Reviews Clinical Oncology 2011; 8(6):378–382.CrossRefPubMed

go back to reference Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B. Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Bmj 1984; 288(6419):749–751. https://doi.org/10.1136/bmj.288.6419.749.CrossRefPubMedPubMedCentral Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B. Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Bmj 1984; 288(6419):749–751. https://​doi.​org/​10.​1136/​bmj.​288.​6419.​749.CrossRefPubMedPubMedCentral

go back to reference Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr H-A, Delaloye J-F, Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2011; 481:85. https://doi.org/10.1038/nature10694 Accessed. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr H-A, Delaloye J-F, Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2011; 481:85. https://​doi.​org/​10.​1038/​nature10694 Accessed.

go back to reference Fidler IJ. Selection of successive tumour lines for metastasis. Nature New Biology 1973; 242(118):148–149. https://doi.org/10.1038/newbio242148a0.CrossRefPubMed Fidler IJ. Selection of successive tumour lines for metastasis. Nature New Biology 1973; 242(118):148–149. https://​doi.​org/​10.​1038/​newbio242148a0.CrossRefPubMed

go back to reference Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR. STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS ONE 2009; 4(6). https://doi.org/10.1371/journal.pone.0005821. Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR. STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS ONE 2009; 4(6). https://​doi.​org/​10.​1371/​journal.​pone.​0005821.

go back to reference Calon A, Espinet E, Palomo-Ponce S, Tauriello DVF, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH-F, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, Sancho E, Batlle E. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer cell 2012; 22(5):571–584. https://doi.org/10.1016/j.ccr.2012.08.013.CrossRefPubMedPubMedCentral Calon A, Espinet E, Palomo-Ponce S, Tauriello DVF, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH-F, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, Sancho E, Batlle E. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer cell 2012; 22(5):571–584. https://​doi.​org/​10.​1016/​j.​ccr.​2012.​08.​013.CrossRefPubMedPubMedCentral

go back to reference Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016; 529(7586):298–306. https://doi.org/10.1038/nature17038.CrossRefPubMedPubMedCentral Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016; 529(7586):298–306. https://​doi.​org/​10.​1038/​nature17038.CrossRefPubMedPubMedCentral

go back to reference Gupta GP, Massagué J. Cancer Metastasis: Building a Framework. Cell 2006; 127(4):679–695.CrossRefPubMed Gupta GP, Massagué J. Cancer Metastasis: Building a Framework. Cell 2006; 127(4):679–695.CrossRefPubMed

go back to reference The deleted in colorectal cancer (DCC) gene: A candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules. Cancer Surveys 1995; 24:3–17. The deleted in colorectal cancer (DCC) gene: A candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules. Cancer Surveys 1995; 24:3–17.

go back to reference Frewer KA, Sanders AJ, Owen S, Frewer NC, Hargest R, Jiang WG. A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics and Proteomics 2013; 10(4):187–196.PubMed Frewer KA, Sanders AJ, Owen S, Frewer NC, Hargest R, Jiang WG. A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics and Proteomics 2013; 10(4):187–196.PubMed

go back to reference Stein MK, Williard FW, Tsao M, Deschner B, Dickson PV, Glazer ES, Martin MG, Deneve JL. Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM). Journal of Clinical Oncology 2019; 37(4_suppl):498–498. https://doi.org/10.1200/jco.2019.37.4_suppl.498.CrossRef Stein MK, Williard FW, Tsao M, Deschner B, Dickson PV, Glazer ES, Martin MG, Deneve JL. Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM). Journal of Clinical Oncology 2019; 37(4_suppl):498–498. https://​doi.​org/​10.​1200/​jco.​2019.​37.​4_​suppl.​498.CrossRef

go back to reference Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova M, Fredriksen T, Mauger S, Waldner M, Berger A, Speicher MR, Pagès F, Valge-Archer V, Galon J. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Science Translational Medicine 2016; 8(327). https://doi.org/10.1126/scitranslmed.aad6352. Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova M, Fredriksen T, Mauger S, Waldner M, Berger A, Speicher MR, Pagès F, Valge-Archer V, Galon J. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Science Translational Medicine 2016; 8(327). https://​doi.​org/​10.​1126/​scitranslmed.​aad6352.

go back to reference Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer and Metastasis Reviews 2003. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer and Metastasis Reviews 2003.

go back to reference Hugen N, Van de Velde CJH, De Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Annals of Oncology 2014; 25(3):651–657. https://doi.org/10.1093/annonc/mdt591.CrossRefPubMedPubMedCentral Hugen N, Van de Velde CJH, De Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Annals of Oncology 2014; 25(3):651–657. https://​doi.​org/​10.​1093/​annonc/​mdt591.CrossRefPubMedPubMedCentral

go back to reference Gendler SJ. MUC1, The renaissance molecule. Journal of Mammary Gland Biology and Neoplasia 2001. Gendler SJ. MUC1, The renaissance molecule. Journal of Mammary Gland Biology and Neoplasia 2001.

go back to reference Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005. https://doi.org/10.1016/j.ccr.2005.01.008. Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005. https://​doi.​org/​10.​1016/​j.​ccr.​2005.​01.​008.

go back to reference Schroeder JA, Adriance MC, Thompson MC, Camenisch TD, Gendler SJ. MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 2003. https://doi.org/10.1038/sj.onc.1206291. Schroeder JA, Adriance MC, Thompson MC, Camenisch TD, Gendler SJ. MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 2003. https://​doi.​org/​10.​1038/​sj.​onc.​1206291.

go back to reference Varghese S, Burness M, Xu H, Beresnev T, Pingpank J, Alexander HR. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Annals of Surgical Oncology 2007; 14(12):3460–3471. https://doi.org/10.1245/s10434-007-9557-7.CrossRefPubMed Varghese S, Burness M, Xu H, Beresnev T, Pingpank J, Alexander HR. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Annals of Surgical Oncology 2007; 14(12):3460–3471. https://​doi.​org/​10.​1245/​s10434-007-9557-7.CrossRefPubMed

go back to reference Lemoine L, Sugarbaker P, Van Der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World Journal of Gastroenterology 2016. Lemoine L, Sugarbaker P, Van Der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World Journal of Gastroenterology 2016.

go back to reference Chiang AC, Massagué J. Molecular Basis of Metastasis. New England Journal of Medicine 2008; 359(26):2814–2823. https://doi.org/10.1056/nejmra0805239.CrossRefPubMed Chiang AC, Massagué J. Molecular Basis of Metastasis. New England Journal of Medicine 2008; 359(26):2814–2823. https://​doi.​org/​10.​1056/​nejmra0805239.CrossRefPubMed

go back to reference Naxerova K, Reiter JG, Brachtel E, Lennerz JK, Van De Wetering M, Rowan A, Cai T, Clevers H, Swanton C, Nowak MA, Elledge SJ, Jain RK. Origins of lymphatic and distant metastases in human colorectal cancer. Science 2017; 357(6346). https://doi.org/10.1126/science.aai8515. Naxerova K, Reiter JG, Brachtel E, Lennerz JK, Van De Wetering M, Rowan A, Cai T, Clevers H, Swanton C, Nowak MA, Elledge SJ, Jain RK. Origins of lymphatic and distant metastases in human colorectal cancer. Science 2017; 357(6346). https://​doi.​org/​10.​1126/​science.​aai8515.

go back to reference Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Annals of Surgical Oncology 2009; 16(2):327–333. https://doi.org/10.1245/s10434-008-0234-2.CrossRefPubMed Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Annals of Surgical Oncology 2009; 16(2):327–333. https://​doi.​org/​10.​1245/​s10434-008-0234-2.CrossRefPubMed

go back to reference Dresen RC, De Vuysere S, De Keyzer F, Van Cutsem E, Prenen H, Vanslembrouck R, De Hertogh G, Wolthuis A, D’Hoore A, Vandecaveye V. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging 2019; 19(1). https://doi.org/10.1186/s40644-018-0187-z. Dresen RC, De Vuysere S, De Keyzer F, Van Cutsem E, Prenen H, Vanslembrouck R, De Hertogh G, Wolthuis A, D’Hoore A, Vandecaveye V. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging 2019; 19(1). https://​doi.​org/​10.​1186/​s40644-018-0187-z.

go back to reference Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. The Lancet Oncology 2017; 18(6):711–712. https://doi.org/10.1016/S1470-2045(17)30336-4.CrossRefPubMed Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. The Lancet Oncology 2017; 18(6):711–712. https://​doi.​org/​10.​1016/​S1470-2045(17)30336-4.CrossRefPubMed

go back to reference Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841. Journal of Clinical Oncology 2012; 30(3):263–267. https://doi.org/10.1200/JCO.2011.37.1039.CrossRefPubMed Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841. Journal of Clinical Oncology 2012; 30(3):263–267. https://​doi.​org/​10.​1200/​JCO.​2011.​37.​1039.CrossRefPubMed

go back to reference Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: 1996:359–374. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: 1996:359–374.

go back to reference Faron M, Macovei R, Goéré D, Honoré C, Benhaim L, Elias D. Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer. Annals of Surgical Oncology 2016; 23(1):114–119. https://doi.org/10.1245/s10434-015-4627-8.CrossRefPubMed Faron M, Macovei R, Goéré D, Honoré C, Benhaim L, Elias D. Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer. Annals of Surgical Oncology 2016; 23(1):114–119. https://​doi.​org/​10.​1245/​s10434-015-4627-8.CrossRefPubMed

go back to reference Sluiter NR, Vlek SL, Wijsmuller AR, Brandsma HT, de Vet HCW, van Grieken NCT, Kazemier G, Tuynman JB. Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques. Annals of Surgical Oncology 2019; 26(1):156–164. https://doi.org/10.1245/s10434-018-7005-5.CrossRefPubMed Sluiter NR, Vlek SL, Wijsmuller AR, Brandsma HT, de Vet HCW, van Grieken NCT, Kazemier G, Tuynman JB. Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques. Annals of Surgical Oncology 2019; 26(1):156–164. https://​doi.​org/​10.​1245/​s10434-018-7005-5.CrossRefPubMed

go back to reference Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Canadian Journal of Surgery 1989; 32(3):164–170. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Canadian Journal of Surgery 1989; 32(3):164–170.

go back to reference Sugarbaker PH. Peritonectomy procedures. In: Peritoneal Carcinomatosis: A Multidisciplinary Approach; 2007:247–264. Sugarbaker PH. Peritonectomy procedures. In: Peritoneal Carcinomatosis: A Multidisciplinary Approach; 2007:247–264.

go back to reference Fernández-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C. In: 2011:51–61. Fernández-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C. In: 2011:51–61.

go back to reference Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116(16):3756–3762. https://doi.org/10.1002/cncr.25116.CrossRefPubMed Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116(16):3756–3762. https://​doi.​org/​10.​1002/​cncr.​25116.CrossRefPubMed

go back to reference Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. Journal of Clinical Oncology 2009; 27(5):681–685. https://doi.org/10.1200/JCO.2008.19.7160.CrossRefPubMed Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. Journal of Clinical Oncology 2009; 27(5):681–685. https://​doi.​org/​10.​1200/​JCO.​2008.​19.​7160.CrossRefPubMed

go back to reference Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Annals of Surgery 2013; 257(6):1065–1071. https://doi.org/10.1097/SLA.0b013e31827e9289.CrossRefPubMed Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Annals of Surgery 2013; 257(6):1065–1071. https://​doi.​org/​10.​1097/​SLA.​0b013e31827e9289​.CrossRefPubMed

go back to reference Cashin PH, Mahteme H, Spång N, Syk I, Frödin JE, Torkzad M, Glimelius B, Graf W. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial. European Journal of Cancer 2016. https://doi.org/10.1016/j.ejca.2015.09.017. Cashin PH, Mahteme H, Spång N, Syk I, Frödin JE, Torkzad M, Glimelius B, Graf W. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial. European Journal of Cancer 2016. https://​doi.​org/​10.​1016/​j.​ejca.​2015.​09.​017.

go back to reference Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. The Lancet Oncology 2013; 14(12):1208–1215. https://doi.org/10.1016/S1470-2045(13)70447-9.CrossRefPubMed Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. The Lancet Oncology 2013; 14(12):1208–1215. https://​doi.​org/​10.​1016/​S1470-2045(13)70447-9.CrossRefPubMed

go back to reference Yoon W, Alame A, Berri R. Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies. American Journal of Surgery 2014; 207(3):403–407. https://doi.org/10.1016/j.amjsurg.2013.09.021.CrossRefPubMed Yoon W, Alame A, Berri R. Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies. American Journal of Surgery 2014; 207(3):403–407. https://​doi.​org/​10.​1016/​j.​amjsurg.​2013.​09.​021.CrossRefPubMed

go back to reference Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, Quadros CA, Somashekhar SP, Ceelen W, Dubé P, Li Y, Verwaal VJ, Glehen O, Piso P, Spiliotis J, Teo MCC, González-Moreno S, Cashin PH, Lehmann K, Deraco M, Moran B, de Hingh IHJT. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). European Journal of Surgical Oncology 2018; 44(12):1942–1948. https://doi.org/10.1016/j.ejso.2018.07.003.CrossRefPubMed Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, Quadros CA, Somashekhar SP, Ceelen W, Dubé P, Li Y, Verwaal VJ, Glehen O, Piso P, Spiliotis J, Teo MCC, González-Moreno S, Cashin PH, Lehmann K, Deraco M, Moran B, de Hingh IHJT. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). European Journal of Surgical Oncology 2018; 44(12):1942–1948. https://​doi.​org/​10.​1016/​j.​ejso.​2018.​07.​003.CrossRefPubMed

go back to reference Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel J. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Annals of Surgical Oncology 2014; 21(5):1501–1505. https://doi.org/10.1245/s10434-013-3061-z.CrossRefPubMed Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel J. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Annals of Surgical Oncology 2014; 21(5):1501–1505. https://​doi.​org/​10.​1245/​s10434-013-3061-z.CrossRefPubMed

go back to reference Désolneux G, Mazière C, Vara J, Brouste V, Fonck M, Béchade D, Bécouarn Y, Evrard S. Cytoreductive surgery of colorectal peritoneal metastases: Outcomes after complete cytoreductive surgery and systemic chemotherapy only. PLoS ONE 2015. https://doi.org/10.1371/journal.pone.0122816. Désolneux G, Mazière C, Vara J, Brouste V, Fonck M, Béchade D, Bécouarn Y, Evrard S. Cytoreductive surgery of colorectal peritoneal metastases: Outcomes after complete cytoreductive surgery and systemic chemotherapy only. PLoS ONE 2015. https://​doi.​org/​10.​1371/​journal.​pone.​0122816.

go back to reference Goere D, Glehen O, Quenet F, Ducreux M, Guilloit J-M, Texier M, Benhamou E, Elias D. Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394). Journal of Clinical Oncology 2018; 36(15_suppl):3531. https://doi.org/10.1200/jco.2018.36.15_suppl.3531.CrossRef Goere D, Glehen O, Quenet F, Ducreux M, Guilloit J-M, Texier M, Benhamou E, Elias D. Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394). Journal of Clinical Oncology 2018; 36(15_suppl):3531. https://​doi.​org/​10.​1200/​jco.​2018.​36.​15_​suppl.​3531.CrossRef

go back to reference Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers A, Bemelman WA, Brandt A, Bremers A, Burger JWA, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok N, Tuynman J, Wiezer MJ, de Wilt JHW, Dijkgraaf MG, Tanis PJ. Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: Primary outcome of the COLOPEC multicenter randomized trial. Journal of Clinical Oncology 2019; 37(4_suppl):482. https://doi.org/10.1200/jco.2019.37.4_suppl.482.CrossRef Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers A, Bemelman WA, Brandt A, Bremers A, Burger JWA, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok N, Tuynman J, Wiezer MJ, de Wilt JHW, Dijkgraaf MG, Tanis PJ. Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: Primary outcome of the COLOPEC multicenter randomized trial. Journal of Clinical Oncology 2019; 37(4_suppl):482. https://​doi.​org/​10.​1200/​jco.​2019.​37.​4_​suppl.​482.CrossRef

go back to reference Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, De La Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA. PD-1 blockade in tumors with mismatch-repair deficiency. New England Journal of Medicine 2015. https://doi.org/10.1056/NEJMoa1500596. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, De La Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA. PD-1 blockade in tumors with mismatch-repair deficiency. New England Journal of Medicine 2015. https://​doi.​org/​10.​1056/​NEJMoa1500596.

go back to reference Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg M V., Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. The Lancet Oncology 2017. https://doi.org/10.1016/S1470-2045(17)30422-9. Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg M V., Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. The Lancet Oncology 2017. https://​doi.​org/​10.​1016/​S1470-2045(17)30422-9.

go back to reference Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S, Xu W, Harmon S, Giles JR, Wenz B, Adamow M, Kuk D, Panageas KS, Carrera C, Wong P, Quagliarello F, Wubbenhorst B, D’Andrea K, Pauken KE, Herati RS, Staupe RP, Schenkel JM, McGettigan S, Kothari S, George SM, Vonderheide RH, Amaravadi RK, Karakousis GC, Schuchter LM, Xu X, Nathanson KL, Wolchok JD, Gangadhar TC, Wherry EJ. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 2017. https://doi.org/10.1038/nature22079. Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S, Xu W, Harmon S, Giles JR, Wenz B, Adamow M, Kuk D, Panageas KS, Carrera C, Wong P, Quagliarello F, Wubbenhorst B, D’Andrea K, Pauken KE, Herati RS, Staupe RP, Schenkel JM, McGettigan S, Kothari S, George SM, Vonderheide RH, Amaravadi RK, Karakousis GC, Schuchter LM, Xu X, Nathanson KL, Wolchok JD, Gangadhar TC, Wherry EJ. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 2017. https://​doi.​org/​10.​1038/​nature22079.

go back to reference Kim CG, Ahn JB, Jung M, Beom SH, Kim C, Kim JH, Heo SJ, Park HS, Kim JH, Kim NK, Min BS, Kim H, Koom WS, Shin SJ. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers. British Journal of Cancer 2016. https://doi.org/10.1038/bjc.2016.161. Kim CG, Ahn JB, Jung M, Beom SH, Kim C, Kim JH, Heo SJ, Park HS, Kim JH, Kim NK, Min BS, Kim H, Koom WS, Shin SJ. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers. British Journal of Cancer 2016. https://​doi.​org/​10.​1038/​bjc.​2016.​161.

go back to reference Tran B, Kopetz S, Tie J, Gibbs P, Jiang ZQ, Lieu CH, Agarwal A, Maru DM, Sieber O, Desai J. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer 2011. https://doi.org/10.1002/cncr.26086. Tran B, Kopetz S, Tie J, Gibbs P, Jiang ZQ, Lieu CH, Agarwal A, Maru DM, Sieber O, Desai J. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer 2011. https://​doi.​org/​10.​1002/​cncr.​26086.

go back to reference Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. British Journal of Surgery 2017. Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. British Journal of Surgery 2017.

go back to reference Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Disease 2016. https://doi.org/10.1111/codi.13130. Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Disease 2016. https://​doi.​org/​10.​1111/​codi.​13130.

go back to reference Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, MacKay CB, Smith HJ, Weir SJ, Wick JA, Markman M, Dizerega GS, Baltezor MJ, Espinosa J, Decedue CJ. A phase i study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies. Cancer Chemotherapy and Pharmacology 2015. https://doi.org/10.1007/s00280-015-2737-4. Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, MacKay CB, Smith HJ, Weir SJ, Wick JA, Markman M, Dizerega GS, Baltezor MJ, Espinosa J, Decedue CJ. A phase i study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies. Cancer Chemotherapy and Pharmacology 2015. https://​doi.​org/​10.​1007/​s00280-015-2737-4.

go back to reference Harrison LE, Bryan M, Pliner L, Saunders T. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy. Annals of Surgical Oncology 2008. https://doi.org/10.1245/s10434-007-9718-8. Harrison LE, Bryan M, Pliner L, Saunders T. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy. Annals of Surgical Oncology 2008. https://​doi.​org/​10.​1245/​s10434-007-9718-8.